Athersys-Partnered Japanese Ischemic Stroke Study Disappoints, Shares Plunge

  • Athersys Inc's ATHX partner, Healios K.K. has reported topline results for its Japan ischemic stroke study, TREASURE. 
  • The study included patients with moderate to moderate-severe ischemic stroke administered a single dose of MultiStem cells (invimestrocel) or placebo by intravenous infusion within 18-36 hours of the event. 
  • The primary endpoint, Excellent Outcome at 90 days, did not reach statistical significance in this population.
  • Overall, consistent improvement in essentially all measured functional outcomes over time through one year, supported long-term impact on and continued improvement in the quality of life of treated patients.
  • The company says that the TREASURE patient population was substantially older than Athersys' MASTERS-1 population with moderately greater stroke severity.
  • It says that the TREASURE study adds considerable new information about the MultiStem treatment effect in patients 80 years and older, not previously studied in MASTERS-1, and who are expected to represent a limited proportion of subjects in the ongoing MASTERS-2 study.
  • The results from the TREASURE study patients with the most relevance for the MASTERS-2 study suggest that MASTERS-2 would be expected to have a high probability of achieving success on the primary endpoint.
  • Price Action: ATHX shares are down 62.9% at $0.28 during the market session on the last check Friday.

Posted In: Briefswhy it's movingBiotechNewsPenny StocksHealth CareMoversTrading IdeasGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.